15-188 - Molecular Analysis for Therapy Choice (MATCH)

Status: open

15-188 Molecular Analysis for Therapy Choice (MATCH)

Treatment for Breast Cancer

Contact Us Or call (251) 445-9834


This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. IRB Number 15-188


This trial is sponsored by National Cancer Institute (NCI).

Providers Associated With This Trial

Principle Investigator

  • Rocconi RodneyView Profile
    Rodney P. Rocconi, M.D., F.A.C.O.G.Gynecologic OncologistInterim Director of Mitchell Cancer Institute; Chief of Gynecologic Oncology Service; Associate Director for Clinical Research, Abraham A. Mitchell Clinical Cancer Research Scholar; Professor of Interdisciplinary Clinical Oncology
This link will open in a new tab or window.